Nektar Therapeutics Overview
Nektar Therapeutics Target Price
Analysts' 12-month price predictions for NKTR.
Get informed when a big investor buys or sells
+ FollowShare Price
$63.65
Average Target Price
$138.40
117.4% upside
117.4% upside5 analysts in the last 4 months
High: $192 | Low: $80
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-11 | WedbushMartin Fan | $80 | 25.7% upside |  |
| 2026-05-08 | Piper SandlerYasmeen Rahimi | $192 | 201.6% upside | |
| 2026-04-21 | Wedbush | $95 | 49.3% upside | |
| 2026-04-20 | H.C. Wainwright | $185 | 190.7% upside | |
| 2026-03-13 | OppenheimerJay Olson | $140 | 120% upside | |
| 2026-02-10 | BTIG | $151 | 137.2% upside | |
| 2026-02-10 | H.C. Wainwright | $165 | 159.2% upside | |
| 2026-01-26 | Piper SandlerYasmeen Rahimi | $105 | 65% upside | |
| 2025-12-16 | H.C. Wainwright | $135 | 112.1% upside | |
| 2025-12-16 | OppenheimerJay Olson | $115 | 80.7% upside | |
| 2025-11-24 | JefferiesRoger Song | $121 | 90.1% upside | |
| 2025-09-18 | JefferiesRoger Song | $99 | 55.5% upside | |
| 2022-04-18 | Mizuho SecuritiesMara Goldstein | $6 |  90.6% downside | |
| 2022-03-01 | J.P. MorganJessica Fye | $17 | 73.3% downside | |
| 2021-11-08 | Ladenburg Thalmann & Co.Aydin Huseynov | $20 | 68.6% downside | |
| 2021-05-18 | Goldman SachsChris Shibutani | $24 | 62.3% downside | |